Report
Recarbrio, an intravenous antibiotic combination for serious antibiotic-resistant infections, discontinued
Chemistry World says Recarbrio was one of three therapies for these infections and examines possible implications for patients.
TLDR
Chemistry World reports that Recarbrio, an intravenous antibiotic combination used for serious antibiotic-resistant infections, has been discontinued. The publication says it was one of three therapies for such infections and explores what the decision may mean for patients.
Combined views
—
1 Source, first seen ago
— likes— comments— saves— reposts